Halvorsen LV, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Liestøl K, Aune A, Olsen E, Brobak KM, Bergland OU, Rognstad S, Aarskog NR, Heimark S, Fadl Elmula FEM, Gerdts E, Mo R, Solbu MD, Opdal MS, Kjeldsen SE, Rostrup M, Høieggen A(2024) Effect of Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial Am J Hypertens(in press) DOI 10.1093/ajh/hpae059, PubMed 38713475
Ree AH, Šaltytė Benth J, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Johansen C, Negård A, Bjørnetrø T, Nilsen HL, Berg JP, Flatmark K, Meltzer S(2024) First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial Br J Cancer(in press) DOI 10.1038/s41416-024-02696-6, PubMed 38664577
Brobak KM, Halvorsen LV, Aass HCD, Søraas CL, Aune A, Olsen E, Bergland OU, Rognstad S, Blom KB, Birkeland JAK, Høieggen A, Larstorp ACK, Solbu MD(2024) Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage Blood Press, 33(1), 2323980 DOI 10.1080/08037051.2024.2323980, PubMed 38606688